Petredis Investment Advisors LLC Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Petredis Investment Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 30,685 shares of the healthcare conglomerate’s stock after selling 832 shares during the period. UnitedHealth Group makes up approximately 1.6% of Petredis Investment Advisors LLC’s investment portfolio, making the stock its 14th largest position. Petredis Investment Advisors LLC’s holdings in UnitedHealth Group were worth $15,522,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Eclectic Associates Inc. ADV boosted its position in UnitedHealth Group by 3.4% in the 4th quarter. Eclectic Associates Inc. ADV now owns 9,798 shares of the healthcare conglomerate’s stock valued at $4,956,000 after buying an additional 320 shares during the period. Goelzer Investment Management Inc. boosted its position in UnitedHealth Group by 10.2% in the 4th quarter. Goelzer Investment Management Inc. now owns 16,532 shares of the healthcare conglomerate’s stock valued at $8,363,000 after buying an additional 1,535 shares during the period. Gradient Investments LLC raised its holdings in shares of UnitedHealth Group by 1.3% in the 4th quarter. Gradient Investments LLC now owns 97,007 shares of the healthcare conglomerate’s stock valued at $49,072,000 after purchasing an additional 1,288 shares in the last quarter. CX Institutional raised its holdings in shares of UnitedHealth Group by 1.0% in the 4th quarter. CX Institutional now owns 10,853 shares of the healthcare conglomerate’s stock valued at $5,490,000 after purchasing an additional 103 shares in the last quarter. Finally, Berbice Capital Management LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $3,542,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE:UNH opened at $532.26 on Friday. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm’s 50-day simple moving average is $542.24 and its 200-day simple moving average is $563.54. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on UNH. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $627.74.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.